Somerset Theraps Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SOMERSET THERAPS LLC, and what generic and branded alternatives to SOMERSET THERAPS LLC drugs are available?
SOMERSET THERAPS LLC has forty-nine approved drugs.
Drugs and US Patents for Somerset Theraps Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Somerset Theraps Llc | CYANOCOBALAMIN | cyanocobalamin | INJECTABLE;INJECTION | 209429-001 | Dec 18, 2018 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Somerset Theraps Llc | METHOCARBAMOL | methocarbamol | SOLUTION;IM-IV | 207522-001 | Jul 31, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Somerset Theraps Llc | TROPICAMIDE | tropicamide | SOLUTION/DROPS;OPHTHALMIC | 207524-001 | Dec 12, 2019 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Somerset Theraps Llc | POTASSIUM PHOSPHATES | potassium phosphate, dibasic; potassium phosphate, monobasic | SOLUTION;INTRAVENOUS | 217726-001 | Jul 11, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Somerset Theraps Llc | CYANOCOBALAMIN | cyanocobalamin | INJECTABLE;INJECTION | 206503-001 | Dec 11, 2015 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Somerset Theraps Llc | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 207636-004 | Jun 15, 2018 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.